Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

140.10
-0.9500-0.67%
Volume:1.25M
Turnover:176.58M
Market Cap:267.31B
PE:21.18
High:141.57
Open:141.45
Low:140.05
Close:141.05
52wk High:170.46
52wk Low:121.57
Shares:1.91B
Float Shares:1.85B
Volume Ratio:1.59
T/O Rate:0.07%
Dividend:4.67
Dividend Rate:3.33%
EPS(TTM):6.61
EPS(LYR):7.15
ROE:30.35%
ROA:10.25%
PB:6.43
PE(LYR):19.59

Loading ...

Movement Alert|Novartis AG Rises 5.19% Overnight, Pauses Eight Autoimmune CAR-T Clinical Trials Following Patient Deaths

Market Focus
·
Sep 01

Novartis Pauses Autoimmune Cell Therapy Studies After Deaths

Dow Jones
·
Sep 01

Novartis AG Falls Monday, Outperforms Market

Dow Jones
·
Sep 01

Novartis AG Falls Thursday, Underperforms Market

Dow Jones
·
Aug 28

Novartis Secures New Chinese Approval for Key Radiopharmaceutical Therapy

Stock News
·
Aug 26

BeOne Medicines' Tacabrutideg Presents 'Sizable Opportunity' in CSU, RBC Says

MT Newswires Live
·
Aug 25

Novartis AG Stock (NVS) Moved Up by 3.82% on Aug 19: Key Drivers Unveiled

TradingKey
·
Aug 20

Movement Alert|Novartis AG Rises 3.11% in Regular Trading, Entresto Patent Victory Reinforces Mid-Term Revenue Outlook

Market Focus
·
Aug 20

The Key to Pharma M&A: Never Shopping Hungry - Heard on the Street

Dow Jones
·
Aug 19

Novartis’ iptacopan granted FDA orphan designation

TIPRANKS
·
Aug 19

Market Chatter: Novartis Wins UK Court Challenge to Entresto Patent

MT Newswires Live
·
Aug 13

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 11

Novartis Might Struggle to Clear Bar in Cholesterol Drug Trial

Dow Jones
·
Aug 10

These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocks

Dow Jones
·
Aug 07

Sarepta Faces Competitive Pressures Despite Pipeline Updates, RBC Says

MT Newswires Live
·
Aug 07

Correction to Novartis Wins FDA Approval for Expanded Prostate Cancer Treatment Article on July 31

Dow Jones
·
Aug 04

Novartis says FDA approves Pluvicto for PSMA+ metastatic prostate cancer

TIPRANKS
·
Aug 01

Berenberg Bank Remains a Hold on Novartis (NVS)

TIPRANKS
·
Jul 28

Berenberg Lifts Price Target on Novartis to $147 From $141, Keeps Hold Rating

MT Newswires Live
·
Jul 27

Novartis price target raised to CHF 142 from CHF 132 at Citi

TIPRANKS
·
Jul 23